In summary, our meta-analysis demonstrated some evidence that the rs2066827 polymorphism of the CDKN1B gene may protect against the development of human cancer, especially ovarian cancer and in Caucasians. This evidence concerns the gene CDKN1B and ovarian carcinoma.